your market intelligence analyst
Search Results
172 results
Your search is now limited to «Bristol-Myers Squibb» expert search.
NASDAQ 11/18/2019 09:18
We note that Bristol-Myers has a tyrosine kinase 2 (TYK2) inhibitor, BMS-986165, in its pipeline, which is being evaluated in several autoimmune diseases, including psoriasis.
More from NASDAQ:
PMLiVE 11/18/2019 05:35
Bristol-Myers Squibb says US regulators have finally given their blessing for its $74bn takeover of Celgene, setting up a completion of the deal on 20 November.
More from PMLiVE:
FiercePharmaManufacturing 11/16/2019 11:49
But the drug's marketers, Bristol-Myers Squibb and Pfizer, believe advanced screening could identify undiagnosed atrial fibrillation patients—and give the drug another leg up.
More from FiercePharmaManufacturing:
Business Wire 11/15/2019 18:39
The Bristol-Myers Squibb Notes offered in the Exchange Offers have not been registered under the Securities Act of 1933, as amended, or any state securities laws.
More from Business Wire:
MarketWatch 11/15/2019 17:43
FTC makes Celgene's Otezla divestiture official condition for Bristol-Myers acquisition.
More from MarketWatch:
Investor's Business Daily 11/15/2019 17:28
X The FTC decision clears the path for Bristol-Myers to wrap its $74 billion Celgene merger on Wednesday, the pharmaceutical company said in a news release.
More from Investor's Business Daily: 11/15/2019 16:56
Bristol-Myers Squibb Co and Celgene Corp have won U.S. antitrust approval for their merger on condition that they sell Celgene's psoriasis drug Otezla, the Federal Trade Commission said in a statement on Friday. (Reporting by Diane Bartz; Editing by Sandra Maler)
More from
FierceMedicalDevices 11/15/2019 08:09
Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA Breakthrough-tagged therapy in the process.
More from FierceMedicalDevices:
Forbes 11/15/2019 07:30
Bristol-Myers Squibb’s (NYSE: BMY) fair price estimate based on expected 2019 earnings is $59, according to Trefis estimates. This is in line with the current market price of around $58. Bristol-Myers Squibb is a biopharmaceutical company that discovers, develops, and sells pharmaceutical...
More from Forbes:
National Law Review 11/12/2019 13:31
Absent clear guidance, district courts have split on whether BMS applies to class actions.
More from National Law Review:
ENDPOINTS 11/12/2019 09:04
With Bristol-Myers Squibb’s Celgene buyout all but complete, the BD teams are working in perfect synchrony now.
More from ENDPOINTS:
Motley Fool 11/12/2019 07:00
And Bristol-Myers Squibb's dividend now looks even better.
More from Motley Fool:
BioPharma Dive 11/07/2019 11:54
With pivotal data for a Celgene CAR-T therapy set to be unveiled, the clock is ticking on a timeline that will determine whether Bristol-Myers pays billions more to the biotech's shareholders.
More from BioPharma Dive:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications